J.B. Chemicals & Pharmaceuticals Lt (Delisted) logo

J.B. Chemicals & Pharmaceuticals Lt (Delisted) share price history

BSE: 506943Pharmaceuticals & Biotechnology

Last traded ₹2,408.90 on 16 Jul 2026

Delisted on 12 Oct 2026.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements

  1. Jul 2026

Share price history

Daily closes since Jan 2007, BSE closes Jan 2007 to Jul 2010, Nov 2012 to Apr 2018 and Jan 2022 to Sep 2023, adjusted for splits and bonuses

Daily close, ₹ per share

ResultsDividend

Results

Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results

Quarter to Mar 2026, against the quarter beforeFiled 13 Jul

Revenue
₹904 Crdown 15.07%
Net profit
₹101 Crdown 48.77%
Net margin
11.2%

Revenue by year

Peak revenue ₹4,148 Cr, year to Mar 2026

Net profit by year, a loss in red

₹ croreJun 2024Filed 9 AugSep 2024Filed 6 NovDec 2024Filed 5 FebMar 2025Filed 12 JunJun 2025Filed 30 JulSep 2025Filed 11 NovDec 2025Filed 16 JanMar 2026Filed 13 Jul
Revenue1,0041,0019639491,0941,0851,065904
Net profit177175162146202208198101
Net margin17.6%17.4%16.9%15.3%18.5%19.2%18.6%11.2%
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.

Business segments

In the year to Mar 2026 the company reports one business segment, Pharmaceuticals, which carries all its revenue.

Where the return came from

Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.

OverReturn a yearEarnings growthChange in P/EDividend yield
1 year+28.2%+4.3%+22.0%1.1%
3 years+28.9%+18.6%+7.9%0.9%
5 years+27.8%+8.8%+16.6%0.9%
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.

Who owns it

Per cent of the company's shares, from the filing for Mar 2026.Shareholding pattern

Shareholding by group

  • Promoters48.80%
  • Foreign institutions16.33%
  • Indian institutions21.38%
  • Individuals and others13.48%
Holder
TORRENT PHARMACEUTICALS LIMITEDPromoter48.80%
KOTAK MIDCAP FUNDMutual funds4.40%
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND A/C AXIS SMALL CAP FUNDMutual funds3.81%
CANARA ROBECO MUTUAL FUND A/C CANARA ROBECO SMALL CAP FUNDMutual funds2.17%
GOVERNMENT PENSION FUND GLOBALForeign portfolio investors, category I1.84%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHARMA FUNDMutual funds1.60%
Holders are named in the company's own words: an insurer's holding can carry one of its funds' names.

Dividends

Per share, by the year it was paid for, and the latest payments.Dividend history and dates

Dividend per share, ₹, restated for later splits and bonuses

Highest ₹22.00 a share, year to Mar 2026.
Ex-dateTypePer share
29 May 2026Final₹9.30
11 Feb 2026Interim₹12.70
30 Jul 2025Final₹7.00
7 Feb 2025Interim₹8.50
14 Aug 2024Final₹6.75
16 Feb 2024Interim₹5.50
Latest payments, as declared, by ex-date.

J.B. Chemicals & Pharmaceuticals Lt share price by year

Each calendar year to 2025.

YearClose at year endChangeHighest closeLowest close
20251,819.70−1.3%1,896.401,504.40
20241,844.15+13.5%1,970.601,531.40
2023BSE close1,624.65+67.2%1,624.65956.68
2022BSE close971.68+9.2%1,059.65718.05
2021889.85+75.0%978.60493.58
2020508.55+139.0%562.93214.75
2019212.83+39.1%215.50149.68
2018BSE close152.95−8.4%171.98124.05
2017BSE close166.95−4.7%179.08129.80
2016BSE close175.28+25.6%197.15118.15
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.

Recent sessions

The last 10 trading days to 16 Jul 2026, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
16 Jul 20262,506.002,525.502,380.002,408.902,418.5647,79,224
15 Jul 20262,491.002,510.002,441.302,506.002,490.907,17,650
14 Jul 20262,460.002,491.002,449.102,487.602,480.658,37,560
13 Jul 20262,415.202,470.002,406.602,460.002,450.234,55,413
10 Jul 20262,440.002,444.802,386.802,435.502,425.074,11,937
9 Jul 20262,436.202,474.002,430.102,444.502,453.802,15,631
8 Jul 20262,426.502,467.702,412.102,435.802,442.4611,69,387
7 Jul 20262,394.802,428.802,390.002,422.002,419.638,23,042
6 Jul 20262,360.002,393.002,350.402,390.002,370.391,69,754
3 Jul 20262,328.002,371.802,327.902,364.602,357.261,08,305
Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.Stock split history

Ex-dateEventPrice factorWhat happened
18 Sep 2023Split0.5000Each share became 2.
29 Aug 2011Price move–A corporate action went ex within three days of this move (Interim Dividend - Rs. - 40.0000, ex-date 29 Aug 2011), and its terms do not account for the move. Not adjusted for.
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout. Any other event is noted and not adjusted for.

Company details

BSE code
506943
ISIN
INE572A01036
Industry
Pharmaceuticals & Biotechnology
Listed
Feb 1986
Face value
₹1
Former symbols
JBCHEPHARM
Website
www.jbpharma.com (opens in a new tab)
CIN
L24390MH1976PLC019380
Corporate identity number, the registrar of companies' code for it